Medications

Developing therapeutic peptides from scorpion venom

Canadian health and wellness company PreveCeutical Medical Inc. (PMI) has signed a research and option agreement with UniQuest, The University of Queensland's main commercialisation company, to develop stabilised natural ...

Arthritis & Rheumatism

Lupus: Peptide P140/LupuzorTM effectiveness confirmed

A clinical trial with 149 patients suffering from the very disabling autoimmune disease systemic lupus erythematosus, has shown the effectiveness of a synthetic peptide developed by a team of researchers led by CNRS biologist ...

page 4 from 4